Neal Birnbaum received his B. Throughout his career, Dr. Birnbaum has enjoyed the diagnostic challenges of rheumatology and the opportunity to work with his patients in developing their individualized treatment programs. Birnbaum is committed to teaching the next generation of physicians, serving as Director of the Division of Rheumatology at California Medical Center since and also as Clinical Professor of Medicine at the University of California San Francisco. He lectures frequently to residents and practicing physicians on various topics in the exciting field of rheumatology. While maintaining a busy practice, Dr.
|Published (Last):||17 December 2004|
|PDF File Size:||1.24 Mb|
|ePub File Size:||5.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
Sponsored by Cell Signaling Technology The role of metabolism in cancer growth and cell survival is an area of growing interest. Beyond fulfilling energy requirements, highly proliferative cells also need to produce excess lipids, nucleotides, and amino acids for the creation of new biomass. In order to do this, a number of metabolic adaptations occur in cancer cells that help generate these metabolites, fuel growth, and may also aid in the evasion of apoptosis.
This webinar will delve into these issues, with the help of our three thought leaders. Vander Heiden is the Howard S. Vander Heiden received his M. Craig Thompson. Lewis Cantley. His research is focused on understanding how cell metabolism is regulated to support proliferation.
Morris J. Birnbaum, M. Birnbaum completed his undergraduate, graduate, and medical training at Brown University in Providence, Rhode Island in the United States before moving to San Francisco to carry out his postdoctoral studies at the University of California.
Birnbaum is currently the associate dean for Biomedical Cores and the associate director of the Institute for Diabetes, Obesity, and Metabolism. The research in his laboratory involves the study of the mechanism of insulin action, metabolism, and how organisms respond to both a deficit and a surfeit of food, with a particular focus on insulin-dependent metabolic pathways.
He recently stepped down as deputy editor of the Journal of Clinical Investigation. Brendan D. Manning, Ph. Manning undertook his doctoral training in the laboratory of Dr. Michael Snyder at Yale University, where he worked on basic mechanisms of mitosis and cell division in budding yeast.
Manning then joined the laboratory of Dr. Lewis Cantley at Harvard Medical School to study mammalian signal transduction pathways for his postdoctoral research. In , Dr. Manning joined the faculty of the then-newly established Department of Genetics and Complex Diseases at the Harvard School of Public Health, where he is now an associate professor.
The ongoing work in his laboratory is delineating the complex molecular wiring and downstream functions of disease-associated signaling networks, with a focus on the interface between metabolism and cancer. This research is revealing novel therapeutic strategies to manipulate these networks for the treatment of common human diseases. Sean Sanders, Ph. Sanders joined TranXenoGen, a startup biotechnology company in Massachusetts working on avian transgenics.
Pursuing his parallel passion for writing and editing, Dr. Currently, Dr. Sponsored by.
Jason M. Birnbaum, M.D.
Sponsored by Cell Signaling Technology The role of metabolism in cancer growth and cell survival is an area of growing interest. Beyond fulfilling energy requirements, highly proliferative cells also need to produce excess lipids, nucleotides, and amino acids for the creation of new biomass. In order to do this, a number of metabolic adaptations occur in cancer cells that help generate these metabolites, fuel growth, and may also aid in the evasion of apoptosis. This webinar will delve into these issues, with the help of our three thought leaders.
Meet the expert - Dr. Rosina Bierbaum
Taukus Erfolgreicher Abschluss der The first commercial-scale plant for the production of Topell biocoal pellets pictured above right — a new type of biomass fuel with similarities to coal and therefore well suited to co-firing see MPS, August boimass is underway in the Netherlands, at Duiven in the province of Gelderland. The plant would expect to use around 2 million tons during the remainder of its life. Ausfall eines Teiles der Brandmeldeanlage. Construction of the pellet plant near the birnbzum of Waycross in southern Georgia started in March Log in or Register. Delicious Digg reddit Facebook StumbleUpon. Neue Doppelblockanlage sichert Zukunft des Standorts. Our intention was to commercialise a new process for the production of efficient biocoal, which significantly improves and extends the potential applications of biomass.